Schizophrenia Current Events | Schizophrenia News | 9
|
| Page
9 of
12 |
226 Results |
|
|
|
Sort By:
Page Views | Date |
NIMH study to guide treatment choices for schizophrenia
A large study funded by NIH's National Institute of Mental Health (NIMH) provides, for the first time, detailed information comparing the effectiveness and side effects of five medications - both new and older medications - that are currently used to treat people with schizophrenia. view more (2005-09-20)
HOPE FOR GENETIC TESTS TO TREAT SCHIZOPHRENIA AND ASTHMA
Scientists are moving a step closer to providing treatment based on a person's genetic profile. Doctors at the Institute of Psychiatry, Kings College, London have found a way to predict the response of an antipsychotic drug called clozapine used for the treatment of schizophrenia. view more (2000-01-04)
Mechanism of nicotine's learning effects explored
While nicotine is highly addictive, researchers have also shown the drug to enhance learning and memory—a property that has launched efforts to develop nicotine-like drugs to treat cognitive deficits in Alzheimer's and Parkinson's diseases, schizophrenia, and attention-deficit/hyperactivity disorder. view more (2007-04-05)
Making memories that last a lifetime
Neurobiologists have discovered a mechanism by which the constantly changing brain retains memories—from that dog bite to that first kiss. They have found that the brain co-opts the same machinery by which cells stably alter their genes to specialize during embryonic development. view more (2007-03-15)
The glutamate decarboxylase 1 gene may play a pivotal role in developing alcoholism
Gamma-aminobutyric acid (GABA) is the major inhibitory neurotransmitter in the brain. GABA has been implicated in the development of alcoholism, although the mechanisms through which this occurs are unclear. view more (2006-10-25)
HEARTS AND MINDS BENEFIT FROM £71M SCIENCE BOOST
Research into heart disease and the workings of the human brain are amongst the projects to benefit from £71m in grants for British science announced today by Science Minister Lord Sainsbury. Grants totalling £24m have been awarded to 14 research projects at 12 universities across the country from a joint DTI, Wellcome Trust and Higher... view more... (2001-04-10)
Looking beyond the drug receptor for clues to drug effectiveness
Antipsychotic drugs that are widely used to treat schizophrenia and other problems may not work as scientists have assumed, according to findings from Duke University Medical Center researchers that could lead to changes in how these drugs are developed and prescribed. view more (2008-08-26)
Developmental delay could stem from nicotinic receptor deletion
The loss of a gene through deletion of genetic material on chromosome 15 is associated with significant abnormalities in learning and behavior, said a consortium of researchers led by Baylor College of Medicine (www.bcm.edu) in a report that appears online today in the journal Nature Genetics. view more (2009-11-09)
Innappropriate drug prescriptions wasting millions, raising health risks
A recent study in Oregon suggests that drugs designed for treating the most severe mental illnesses are often prescribed at inappropriately low doses and at considerable expense, for use in conditions where their benefit has not been established. view more (2009-03-05)
Doctors have trouble talking to patients about psychotic symptoms
Doctors have trouble talking to patients about psychotic symptoms, finds a study in this week’s BMJ. view more (2002-11-13)
Nicotine may have more profound impact than previously thought
Nicotine isn't just addictive. It may also interfere with dozens of cellular interactions in the body, new Brown University research suggests. view more (2009-04-06)
Homicide by mentally ill has risen in England and Wales
The number of people killed by individuals suffering from mental illness in England and Wales increased between 1997 and 2005, figures released today show. view more (2009-07-29)
Activation of the prefrontal cortex improves working memory
Psychologists and neurologists invest considerable effort in the study of working memory. In terms of information retention, there is a difference between long-term memory, which is affected in diseases such as Alzheimer, and short-term or working memory, which allows us to make immediate decisions or structure a discourse. view more (2009-04-02)
£2 Million of Yeast Could Triple Available Drug Treatments
Researchers are to employ the humble yeast cell to greatly increase – perhaps even triple - the number of drug treatments for common diseases such as allergies, asthma, obesity, type 2 diabetes, schizophrenia, heart disease, osteoporosis and cancer. view more (2003-02-05)
Growth factor protects brain against damage from stroke
A naturally occurring growth factor called neuregulin-1 protects brain cells from damage resulting from stroke, according to an animal study conducted by researchers at Morehouse School of Medicine (MSM) and the Atlanta-based Center for Behavioral Neuroscience (CBN). view more (2005-12-14)
Lower childhood IQ associated with higher risk of adult mental disorders
Researchers have hypothesized that people with lower IQs may have a higher risk of adult mental disorders, but few studies have looked at the relationship between low childhood IQ and psychiatric disorders later in life. view more (2008-12-01)
ADHD genes found, known to play roles in neurodevelopment
Pediatric researchers have identified hundreds of gene variations that occur more frequently in children with attention-deficit hyperactivity disorder (ADHD) than in children without ADHD. view more (2009-06-24)
Does racial stereotyping still occur in psychiatry?
Ten years ago, psychiatrists rated black male patients as potentially more violent than white patients. A study in this week's BMJ asks does such racial stereotyping still occur? A postal questionnaire, concerning the first presentation of a young man at casualty, was sent to 1000 British psychiatrists. It included a photograph, brief history, and... view more... (2001-10-17)
First generation antipsychotic drugs as effective as newer ones in some children
Nearly every child who receives an antipsychotic medicine is first prescribed one of the second-generation, or "atypical" drugs, such as olanzapine and risperidone. However, there has never been evidence that these drugs are more effective than the older, first-generation medications. view more (2008-09-15)
Clear public health message on cannabis needed
Smoking cannabis, like smoking tobacco, can be a major public health hazard but, at present, there is no clear public health message about cannabis, argue researchers in this week's BMJ. The number of cannabis smokers is increasing. Between 1999 and 2001, the number of 14-15 year olds who had tried cannabis rose from 19% to 29% in boys and 18% to... view more... (2003-04-30)
|
|
| Page
9 of
12 |
226 Results |
|
|
|
Sort By:
Page Views | Date |
|
